@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<http://hl7.eu/fhir/ig/gravitate-health/Composition/d19473ec-d66c-443d-bd8f-31398daaffee> a fhir:Composition;
  fhir:nodeRole fhir:treeRoot;
  fhir:Resource.id [ fhir:value "d19473ec-d66c-443d-bd8f-31398daaffee"];
  fhir:Resource.meta [
     fhir:Meta.profile [
       fhir:value "http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Composition-uv-epi";
       fhir:index 0;
       fhir:link <http://hl7.eu/fhir/ig/gravitate-health/StructureDefinition/Composition-uv-epi>
     ]
  ];
  fhir:Resource.language [ fhir:value "ja"];
  fhir:DomainResource.text [
     fhir:Narrative.status [ fhir:value "generated" ];
     fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"ja\" lang=\"ja\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"d19473ec-d66c-443d-bd8f-31398daaffee\"  (Language \"ja\") </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Composition-uv-epi.html\">Composition (ePI)</a></p></div><p><b>status</b>: final</p><p><b>type</b>: Package Leaflet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#100000155538)</span></p><p><b>date</b>: 2002-08-01 01:28:17+0000</p><p><b>author</b>: <a href=\"Organization-7f257409-3b65-401d-a246-7ae51e298fbb.html\">Organization/7f257409-3b65-401d-a246-7ae51e298fbb</a> \"Pfizer, Inc.\"</p><p><b>title</b>: TEST PURPOSES ONLY - Aromasin (exemestane) Tablets 25 mg tablets</p><p><b>confidentiality</b>: U</p><h3>Attesters</h3><table class=\"grid\"><tr><td>-</td><td><b>Mode</b></td><td><b>Time</b></td></tr><tr><td>*</td><td>Official <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://build.fhir.org/codesystem-composition-attestation-mode.html\">CompositionAttestationMode</a>#official)</span></td><td>2002-08-01 01:28:17+0000</td></tr></table></div>"
  ];
  fhir:Composition.status [ fhir:value "final"];
  fhir:Composition.type [
     fhir:CodeableConcept.coding [
       fhir:index 0;
       fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/" ];
       fhir:Coding.code [ fhir:value "100000155538" ]
     ];
     fhir:CodeableConcept.text [ fhir:value "Package Leaflet" ]
  ];
  fhir:Composition.subject [
     fhir:link <http://hl7.eu/fhir/ig/gravitate-health/RegulatedAuthorization/15c6f86f-8665-4bd6-86da-a3a61fe16084>;
     fhir:Reference.reference [ fhir:value "RegulatedAuthorization/15c6f86f-8665-4bd6-86da-a3a61fe16084" ]
  ];
  fhir:Composition.date [ fhir:value "2002-08-01T13:28:17Z"^^xsd:dateTime];
  fhir:Composition.author [
     fhir:index 0;
     fhir:link <http://hl7.eu/fhir/ig/gravitate-health/Organization/7f257409-3b65-401d-a246-7ae51e298fbb>;
     fhir:Reference.reference [ fhir:value "Organization/7f257409-3b65-401d-a246-7ae51e298fbb" ]
  ];
  fhir:Composition.title [ fhir:value "TEST PURPOSES ONLY - Aromasin (exemestane) Tablets 25 mg tablets"];
  fhir:Composition.confidentiality [ fhir:value "U"];
  fhir:Composition.attester [
     fhir:index 0;
     fhir:Composition.attester.mode [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "http://hl7.org/fhir/composition-attestation-mode" ];
         fhir:Coding.code [ fhir:value "official" ]
       ]
     ];
     fhir:Composition.attester.time [ fhir:value "2002-08-01T13:28:17Z"^^xsd:dateTime ]
  ];
  fhir:Composition.section [
     fhir:index 0;
     fhir:Composition.section.title [ fhir:value "アロマターゼ阻害剤/閉経後乳癌治療剤" ];
     fhir:Composition.section.code [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
         fhir:Coding.code [ fhir:value "0" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "アロマターゼ阻害剤/閉経後乳癌治療剤" ]
     ];
     fhir:Composition.section.text [
       fhir:Narrative.status [ fhir:value "additional" ];
       fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>アロマターゼ阻害剤/閉経後乳癌治療剤</p><p>エキセメスタン錠</p><p><img src=\"figure0-aromasin-header.png\" alt=\"Aromasin Tablets 25mg\"/></p><p><img src=\"figure0-aromasin-header.png\" alt=\"Aromasin Tablets 25mg\"/></p></div>"
     ]
  ], [
     fhir:index 1;
     fhir:Composition.section.title [ fhir:value "1. 警告" ];
     fhir:Composition.section.code [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
         fhir:Coding.code [ fhir:value "1" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "1. 警告" ]
     ];
     fhir:Composition.section.text [
       fhir:Narrative.status [ fhir:value "additional" ];
       fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
     ];
     fhir:Composition.section.emptyReason [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
         fhir:Coding.code [ fhir:value "1" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "Not Applicable" ]
     ]
  ], [
     fhir:index 2;
     fhir:Composition.section.title [ fhir:value "2. 禁忌(次の患者には投与しないこと)" ];
     fhir:Composition.section.code [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
         fhir:Coding.code [ fhir:value "2" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "禁忌(次の患者には投与しないこと)" ]
     ];
     fhir:Composition.section.text [
       fhir:Narrative.status [ fhir:value "additional" ];
       fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
     ];
     fhir:Composition.section.section [
       fhir:index 0;
       fhir:Composition.section.title [ fhir:value "2.1" ];
       fhir:Composition.section.code [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "2.1" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "2.1" ]
       ];
       fhir:Composition.section.text [
         fhir:Narrative.status [ fhir:value "additional" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>妊婦又は妊娠している可能性のある女性[9.5参照]</p></div>"
       ]
     ], [
       fhir:index 1;
       fhir:Composition.section.title [ fhir:value "2.2" ];
       fhir:Composition.section.code [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "2.2" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "2.2" ]
       ];
       fhir:Composition.section.text [
         fhir:Narrative.status [ fhir:value "additional" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>授乳婦[9.6参照]</p></div>"
       ]
     ], [
       fhir:index 2;
       fhir:Composition.section.title [ fhir:value "2.3" ];
       fhir:Composition.section.code [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "2.3" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "2.3" ]
       ];
       fhir:Composition.section.text [
         fhir:Narrative.status [ fhir:value "additional" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>本剤の成分に対し過敏症の既往歴のある患者</p></div>"
       ];
       fhir:Composition.section.emptyReason [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "1" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Not Applicable" ]
       ]
     ]
  ], [
     fhir:index 3;
     fhir:Composition.section.title [ fhir:value "3. 組成・性状" ];
     fhir:Composition.section.code [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
         fhir:Coding.code [ fhir:value "3" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "3. 組成・性状" ]
     ];
     fhir:Composition.section.text [
       fhir:Narrative.status [ fhir:value "additional" ];
       fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
     ];
     fhir:Composition.section.section [
       fhir:index 0;
       fhir:Composition.section.title [ fhir:value "3.1 組成" ];
       fhir:Composition.section.code [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "3.1" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "3.1 組成" ]
       ];
       fhir:Composition.section.text [
         fhir:Narrative.status [ fhir:value "additional" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table border=\"1\" width=\"100%\"><tr><td style=\"text-align:center\"><p>販売名</p></td><td style=\"text-align:center\"><p>アロマシン錠 25mg</p></td></tr><tr><td style=\"text-align:center\"><p>有 効 成 分</p></td><td style=\"text-align:center\"><p>1錠中 エキセメスタン 25.000mg</p></td></tr><tr><td style=\"text-align:center\"><p>添 加 剤</p></td><td><p>カルナウバロウ、デンプングリコール酸ナトリウム、クロスポビドン、軽 質無水ケイ酸、結晶セルロース、合成ワックス、酸化チタン、シリコン消 泡剤、ステアリン酸マグネシウム、精製白糖、タルク、炭酸マグネシウム、 パラオキシ安息香酸メチル、ヒプロメロース、ポリソルベート80、ポリビ ニルアルコール(部分けん化物)、ポリエチレングリコール6000NF、D-マ ンニトール</p></td></tr></table></div>"
       ]
     ], [
       fhir:index 1;
       fhir:Composition.section.title [ fhir:value "3.2 製剤の性状" ];
       fhir:Composition.section.code [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "3.2" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "3.2 製剤の性状" ]
       ];
       fhir:Composition.section.text [
         fhir:Narrative.status [ fhir:value "additional" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table border=\"1\" width=\"100%\"><tr><td colspan=\"3\" style=\"text-align:center\"><p>外 形</p></td><td rowspan=\"2\" style=\"text-align:center\"><p>識別コード</p></td><td rowspan=\"2\" style=\"text-align:center\"><p>色調等</p></td></tr><tr><td style=\"text-align:center\"><p>上面</p></td><td style=\"text-align:center\"><p>下面</p></td><td style=\"text-align:center\"><p>側面</p></td></tr><tr><td style=\"text-align:center\"><img alt=\"Aromasin Tablets 25mg\" src=\"aromasin-tablet-shape-above.png\"/></td><td style=\"text-align:center\"><p>image2</p></td><td style=\"text-align:center\"><p>image3</p></td><td rowspan=\"3\" style=\"text-align:center\"><p>7663</p></td><td rowspan=\"3\" style=\"text-align:center\"><p>白色~微灰白色</p><p>糖衣錠</p><p></p></td></tr><tr><td style=\"text-align:center\"><p>直径</p></td><td style=\"text-align:center\"><p>厚さ</p></td><td style=\"text-align:center\"><p>重量</p></td></tr><tr><td style=\"text-align:center\"><p>6.0mm</p></td><td style=\"text-align:center\"><p>4.0mm</p></td><td style=\"text-align:center\"><p>100mg</p></td></tr></table></div>"
       ]
     ]
  ], [
     fhir:index 4;
     fhir:Composition.section.title [ fhir:value "4. 効能又は効果" ];
     fhir:Composition.section.code [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
         fhir:Coding.code [ fhir:value "4" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "効能又は効果" ]
     ];
     fhir:Composition.section.text [
       fhir:Narrative.status [ fhir:value "additional" ];
       fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">閉経後乳癌</div>"
     ]
  ], [
     fhir:index 5;
     fhir:Composition.section.title [ fhir:value "5. 効能又は効果に関連する注意" ];
     fhir:Composition.section.code [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
         fhir:Coding.code [ fhir:value "5" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "効能又は効果に関連する注意" ]
     ];
     fhir:Composition.section.text [
       fhir:Narrative.status [ fhir:value "additional" ];
       fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
     ];
     fhir:Composition.section.emptyReason [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
         fhir:Coding.code [ fhir:value "1" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "Not Applicable" ]
     ]
  ], [
     fhir:index 6;
     fhir:Composition.section.title [ fhir:value "6. 用法及び用量" ];
     fhir:Composition.section.code [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
         fhir:Coding.code [ fhir:value "6" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "用法及び用量" ]
     ];
     fhir:Composition.section.text [
       fhir:Narrative.status [ fhir:value "additional" ];
       fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">通常、成人にはエキセメスタンとして1日1回25mgを食後に経口投 与する。</div>"
     ]
  ], [
     fhir:index 7;
     fhir:Composition.section.title [ fhir:value "7. 用法及び用量に関連する注意" ];
     fhir:Composition.section.code [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
         fhir:Coding.code [ fhir:value "7" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "7. 用法及び用量に関連する注意" ]
     ];
     fhir:Composition.section.text [
       fhir:Narrative.status [ fhir:value "additional" ];
       fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
     ];
     fhir:Composition.section.emptyReason [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
         fhir:Coding.code [ fhir:value "1" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "Not Applicable" ]
     ]
  ], [
     fhir:index 8;
     fhir:Composition.section.title [ fhir:value "8. 重要な基本的注意" ];
     fhir:Composition.section.code [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
         fhir:Coding.code [ fhir:value "8" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "重要な基本的注意" ]
     ];
     fhir:Composition.section.text [
       fhir:Narrative.status [ fhir:value "additional" ];
       fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p></p></div>"
     ];
     fhir:Composition.section.section [
       fhir:index 0;
       fhir:Composition.section.title [ fhir:value "8.1" ];
       fhir:Composition.section.code [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "8.1" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "8.1" ]
       ];
       fhir:Composition.section.text [
         fhir:Narrative.status [ fhir:value "additional" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">本剤はホルモン療法剤であり、がんに対する薬物療法について十 分な知識・経験を持つ医師のもとで、本剤による治療が適切と判断 される患者についてのみ使用すること。</div>"
       ]
     ], [
       fhir:index 1;
       fhir:Composition.section.title [ fhir:value "8.2" ];
       fhir:Composition.section.code [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "8.2" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "8.2" ]
       ];
       fhir:Composition.section.text [
         fhir:Narrative.status [ fhir:value "additional" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">本剤は末梢アロマターゼを阻害することにより治療効果を発揮す るものであり、活発な卵巣機能を有する閉経前の患者ではアロマ ターゼを阻害する効果は不十分であると予想されること、並びに閉 経前の患者では使用経験がないことを考慮して、閉経前患者に対し 使用しないこと。</div>"
       ]
     ], [
       fhir:index 2;
       fhir:Composition.section.title [ fhir:value "8.3" ];
       fhir:Composition.section.code [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "8.3" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "8.3" ]
       ];
       fhir:Composition.section.text [
         fhir:Narrative.status [ fhir:value "additional" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">本剤の投与によって、骨粗鬆症、骨折が起こりやすくなるので、 骨密度等の骨状態を定期的に観察することが望ましい。</div>"
       ]
     ], [
       fhir:index 3;
       fhir:Composition.section.title [ fhir:value "8.4" ];
       fhir:Composition.section.code [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "8.4" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "8.4" ]
       ];
       fhir:Composition.section.text [
         fhir:Narrative.status [ fhir:value "additional" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">本剤の使用による嗜眠、傾眠、無力(症)及びめまいが報告され ており、このような症状がある場合、機械操作や自動車の運転はさ せないよう十分注意すること。</div>"
       ]
     ]
  ], [
     fhir:index 9;
     fhir:Composition.section.title [ fhir:value "9. 特定の背景を有する患者に関する注意" ];
     fhir:Composition.section.code [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
         fhir:Coding.code [ fhir:value "9" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "特定の背景を有する患者に関する注意" ]
     ];
     fhir:Composition.section.text [
       fhir:Narrative.status [ fhir:value "additional" ];
       fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p></p></div>"
     ];
     fhir:Composition.section.section [
       fhir:index 0;
       fhir:Composition.section.title [ fhir:value "9.2 腎機能障害患者" ];
       fhir:Composition.section.code [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "9.2" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "9.2 腎機能障害患者" ]
       ];
       fhir:Composition.section.text [
         fhir:Narrative.status [ fhir:value "additional" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
       ];
       fhir:Composition.section.section [
         fhir:index 0;
         fhir:Composition.section.title [ fhir:value "9.3.1 重度の肝障害のある患者" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "9.3.1" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "9.3.1 重度の肝障害のある患者" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">本剤の重度の肝障害患者における長期安全性を指標とした臨床試験 は実施していない。</div>"
         ]
       ]
     ], [
       fhir:index 1;
       fhir:Composition.section.title [ fhir:value "9.2.1 重度の腎障害のある患者" ];
       fhir:Composition.section.code [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "9" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "9.2.1 重度の腎障害のある患者" ]
       ];
       fhir:Composition.section.text [
         fhir:Narrative.status [ fhir:value "additional" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">本剤の重度の腎障害患者における長期安全性を指標とした臨床試験 は実施していない。</div>"
       ]
     ], [
       fhir:index 2;
       fhir:Composition.section.title [ fhir:value "9.3 肝機能障害患者" ];
       fhir:Composition.section.code [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "9.3" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "9.3 肝機能障害患者" ]
       ];
       fhir:Composition.section.text [
         fhir:Narrative.status [ fhir:value "additional" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
       ]
     ], [
       fhir:index 3;
       fhir:Composition.section.title [ fhir:value "9.4" ];
       fhir:Composition.section.code [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "9.4" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "9.4" ]
       ];
       fhir:Composition.section.text [
         fhir:Narrative.status [ fhir:value "additional" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
       ]
     ], [
       fhir:index 4;
       fhir:Composition.section.title [ fhir:value "9.5 妊婦" ];
       fhir:Composition.section.code [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "9" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "9.5 妊婦" ]
       ];
       fhir:Composition.section.text [
         fhir:Narrative.status [ fhir:value "additional" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">妊婦又は妊娠している可能性のある女性には投与しないこと。本剤 は、閉経後の患者を対象とするため、妊婦に対する投与は想定され ていないが、妊婦への投与の安全性については次の知見がある。動 物実験(ラット)で、分娩障害、妊娠期間の延長、吸収胚数の増加 及び生存胎児数の減少が認められている。また動物実験(ウサギ)で、 流産、吸収胚数の増加及び胎児体重の低下が認められている。しか し両種による動物実験で、催奇形性は認められてはいない。本剤の 妊婦又は妊娠している可能性のある女性における臨床使用経験はな い。[2.1参照]</div>"
       ]
     ], [
       fhir:index 5;
       fhir:Composition.section.title [ fhir:value "9.6 授乳婦" ];
       fhir:Composition.section.code [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "9.6" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "9.6 授乳婦" ]
       ];
       fhir:Composition.section.text [
         fhir:Narrative.status [ fhir:value "additional" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">投与しないこと。本剤は、閉経後の患者を対象とするため、授乳婦に 対する投与は想定されていないが、授乳婦への投与の安全性について は次の知見がある。動物実験(ラット)で乳汁中への移行が認められ ている。本剤の授乳中の女性における臨床使用経験はない。[2.2参照]</div>"
       ]
     ]
  ], [
     fhir:index 10;
     fhir:Composition.section.title [ fhir:value "10. 相互作用" ];
     fhir:Composition.section.code [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
         fhir:Coding.code [ fhir:value "10" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "10. 相互作用" ]
     ];
     fhir:Composition.section.text [
       fhir:Narrative.status [ fhir:value "additional" ];
       fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p></p></div>"
     ];
     fhir:Composition.section.section [
       fhir:index 0;
       fhir:Composition.section.title [ fhir:value "10.1" ];
       fhir:Composition.section.code [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "9" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "10.1" ]
       ];
       fhir:Composition.section.text [
         fhir:Narrative.status [ fhir:value "additional" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
       ];
       fhir:Composition.section.emptyReason [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "1" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "Not Applicable" ]
       ]
     ], [
       fhir:index 1;
       fhir:Composition.section.title [ fhir:value "10.2 併用注意(併用に注意すること)" ];
       fhir:Composition.section.code [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "10" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "10.2 併用注意(併用に注意すること)" ]
       ];
       fhir:Composition.section.text [
         fhir:Narrative.status [ fhir:value "additional" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table border=\"1\"><tr><td><p>>薬剤名等</p></td><td><p>臨床症状・措置方法</p></td><td><p>機序・危険因子</p></td></tr><tr><td><p>エストロゲン含有製剤</p></td><td><p>本剤の効果を減弱させる可</p><p>能性がある。</p></td><td><p>本剤の薬理作用はエストロゲン</p><p>合成阻害によるものであるため。</p></td></tr></table></div>"
       ]
     ]
  ], [
     fhir:index 11;
     fhir:Composition.section.title [ fhir:value "11. 副作用" ];
     fhir:Composition.section.code [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
         fhir:Coding.code [ fhir:value "11" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "11. 副作用" ]
     ];
     fhir:Composition.section.text [
       fhir:Narrative.status [ fhir:value "additional" ];
       fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>次の副作用があらわれることがあるので、観察を十分に行い、異常 が認められた場合には投与を中止するなど適切な処置を行うこと。</p></div>"
     ];
     fhir:Composition.section.section [
       fhir:index 0;
       fhir:Composition.section.title [ fhir:value "11.1 重大な副作用" ];
       fhir:Composition.section.code [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "11.1" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "11.1 重大な副作用" ]
       ];
       fhir:Composition.section.text [
         fhir:Narrative.status [ fhir:value "additional" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"></div>"
       ];
       fhir:Composition.section.section [
         fhir:index 0;
         fhir:Composition.section.title [ fhir:value "11.1.1" ];
         fhir:Composition.section.code [
           fhir:CodeableConcept.coding [
             fhir:index 0;
             fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
             fhir:Coding.code [ fhir:value "11.1.1" ]
           ];
           fhir:CodeableConcept.text [ fhir:value "11.1.1" ]
         ];
         fhir:Composition.section.text [
           fhir:Narrative.status [ fhir:value "additional" ];
           fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">肝炎(頻度不明)、肝機能障害(頻度不明)、黄疸(頻度不明) 肝炎、AST、ALT、Al-P、 γ-GTP等の上昇を伴う肝機能障害、 黄疸があらわれることがある。</div>"
         ]
       ]
     ], [
       fhir:index 1;
       fhir:Composition.section.title [ fhir:value "11.2 その他の副作用" ];
       fhir:Composition.section.code [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "11.2" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "11.2 その他の副作用" ]
       ];
       fhir:Composition.section.text [
         fhir:Narrative.status [ fhir:value "additional" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table border=\"1\"><tbody><tr><td></td><td><p>5%以上</p></td><td><p>0.1~5%未満</p></td><td><p>頻度不明</p></td></tr><tr><td><p>精神神経系</p></td><td><p>多汗、めまい</p></td><td><p>しびれ(感)、頭痛、知覚障害、 ふらつき(感)、不眠(症)、 抑うつ、不安、手根管症候群</p></td><td><p>傾眠</p></td></tr><tr><td><p>消化器</p></td><td><p>悪心</p></td><td><p>食欲不振、腹痛、嘔吐、腸管 閉塞、のどの通過障害感、胃 もたれ感、心窩部痛(心窩部 の疼痛)、下痢</p></td><td></td></tr><tr><td><p>肝臓</p></td><td></td><td></td><td><p>肝機能異常、Al-P 上昇</p></td></tr><tr><td><p>皮膚</p></td><td></td><td><p>発疹、脱毛(症)、爪の変化</p></td><td><p>蕁麻疹、そう痒症</p></td></tr><tr><td><p>筋骨格系</p></td><td></td><td><p>関節痛、筋骨格痛</p></td><td><p>骨折、骨粗鬆症、弾 発指、狭窄性腱鞘炎</p></td></tr><tr><td><p>循環器</p></td><td><p>高血圧</p></td><td><p>動悸、低血圧</p></td><td></td></tr><tr><td><p>呼吸器</p></td><td></td><td><p>鼻出血、かぜ症候群、肺炎</p></td><td></td></tr><tr><td><p>泌尿器</p></td><td></td><td><p>膀胱炎、尿検査異常</p></td><td></td></tr><tr><td><p>生殖器</p></td><td></td><td><p>不正(子宮)出血、帯下</p></td><td></td></tr><tr><td><p>その他</p></td><td><p>ほてり、疲労</p></td><td><p>疼痛、体重減少、倦怠(感)、体臭、</p><p>浮腫、味覚異常、嗅覚障害</p></td><td><p>過敏症</p></td></tr></tbody></table></div>"
       ]
     ]
  ], [
     fhir:index 12;
     fhir:Composition.section.title [ fhir:value "12. 臨床検査結果に及ぼす影響" ];
     fhir:Composition.section.code [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
         fhir:Coding.code [ fhir:value "12" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "12. 臨床検査結果に及ぼす影響" ]
     ];
     fhir:Composition.section.text [
       fhir:Narrative.status [ fhir:value "additional" ];
       fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p></p></div>"
     ];
     fhir:Composition.section.emptyReason [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
         fhir:Coding.code [ fhir:value "1" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "Not Applicable" ]
     ]
  ], [
     fhir:index 13;
     fhir:Composition.section.title [ fhir:value "13. 過量投与" ];
     fhir:Composition.section.code [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
         fhir:Coding.code [ fhir:value "13" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "13. 過量投与" ]
     ];
     fhir:Composition.section.text [
       fhir:Narrative.status [ fhir:value "additional" ];
       fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p></p></div>"
     ];
     fhir:Composition.section.emptyReason [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
         fhir:Coding.code [ fhir:value "1" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "Not Applicable" ]
     ]
  ], [
     fhir:index 14;
     fhir:Composition.section.title [ fhir:value "14. 適用上の注意" ];
     fhir:Composition.section.code [
       fhir:CodeableConcept.coding [
         fhir:index 0;
         fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
         fhir:Coding.code [ fhir:value "14" ]
       ];
       fhir:CodeableConcept.text [ fhir:value "14. 適用上の注意" ]
     ];
     fhir:Composition.section.text [
       fhir:Narrative.status [ fhir:value "additional" ];
       fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p></p></div>"
     ];
     fhir:Composition.section.section [
       fhir:index 0;
       fhir:Composition.section.title [ fhir:value "14.1 薬剤交付時の注意" ];
       fhir:Composition.section.code [
         fhir:CodeableConcept.coding [
           fhir:index 0;
           fhir:Coding.system [ fhir:value "https://pmda.jp/" ];
           fhir:Coding.code [ fhir:value "14.1" ]
         ];
         fhir:CodeableConcept.text [ fhir:value "14.1 薬剤交付時の注意" ]
       ];
       fhir:Composition.section.text [
         fhir:Narrative.status [ fhir:value "additional" ];
         fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\">PTP包装の薬剤はPTPシートから取り出して服用するよう指導するこ と。PTPシートの誤飲により、硬い鋭角部が食道粘膜へ刺入し、更に は穿孔をおこして縦隔洞炎等の重篤な合併症を併発することがある。</div>"
       ]
     ]
  ] .

# - ontology header ------------------------------------------------------------

<http://hl7.eu/fhir/ig/gravitate-health/Composition/d19473ec-d66c-443d-bd8f-31398daaffee.ttl> a owl:Ontology;
  owl:imports fhir:fhir.ttl .

# -------------------------------------------------------------------------------------

